Ayres, Lorena Rocha; Campos, Marília Silveira de Almeida; Gozzo, Thais de Oliveira 
; Martinez, Edson Zangiacomi; Ungari, Andrea Queiróz; Andrade, Jurandyr Moreira; Pereira, Leonardo Régis Leira
Source: International Journalof Clinical Pharmacy. Unidades: FCFRP, EERP, FMRP
Subjects: NEOPLASIAS MAMÁRIAS, FÁRMACOS, QUALIDADE DE VIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AYRES, Lorena Rocha et al. Trastuzumab induced cardiotoxicity in HER2 positive breast cancer patients attended in a tertiary hospital. International Journalof Clinical Pharmacy, v. 37, n. 2, p. 365-372, 2015Tradução . . Disponível em: https://doi.org/10.1007/s11096-015-0070-y. Acesso em: 01 nov. 2024.APA
Ayres, L. R., Campos, M. S. de A., Gozzo, T. de O., Martinez, E. Z., Ungari, A. Q., Andrade, J. M., & Pereira, L. R. L. (2015). Trastuzumab induced cardiotoxicity in HER2 positive breast cancer patients attended in a tertiary hospital. International Journalof Clinical Pharmacy, 37( 2), 365-372. doi:10.1007/s11096-015-0070-yNLM
Ayres LR, Campos MS de A, Gozzo T de O, Martinez EZ, Ungari AQ, Andrade JM, Pereira LRL. Trastuzumab induced cardiotoxicity in HER2 positive breast cancer patients attended in a tertiary hospital [Internet]. International Journalof Clinical Pharmacy. 2015 ; 37( 2): 365-372.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s11096-015-0070-yVancouver
Ayres LR, Campos MS de A, Gozzo T de O, Martinez EZ, Ungari AQ, Andrade JM, Pereira LRL. Trastuzumab induced cardiotoxicity in HER2 positive breast cancer patients attended in a tertiary hospital [Internet]. International Journalof Clinical Pharmacy. 2015 ; 37( 2): 365-372.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s11096-015-0070-y
